Top Markets
Coin of the day
PharmaSGP Holding SE PharmaSGP Holding SE

PharmaSGP Holding SE

PSG
株式のランク #14723
Founded in 2012 and based in Gräfelfing, Germany, PharmaSGP Holding SE... Founded in 2012 and based in Gräfelfing, Germany, PharmaSGP Holding SE specializes in the production of over-the-counter (OTC) pharmaceuticals and diverse healthcare goods. The company offers an extensive portfolio of products addressing various health concerns. This includes Baldriparan for sleep disturbances; pain relief solutions like Spalt, Formigran, and Kamol massage cream; RubaXX, specifically designed for rheumatic pain in bones, tendons, and muscles; and Restaxil, which targets nerve pain in the neck and back. Furthermore, their offerings encompass Fulminan, a beauty beverage for areas such as the eyes, buttocks, and thighs; DESEO drops for sexual weakness; Neradin, a medication for sexual dysfunction; and TAUMEA, aimed at managing vertigo. PharmaSGP also develops treatments for chronic conditions, including persistent pain and other age-associated ailments. Its products reach consumers via pharmacies and wholesalers, and are exported to several European nations, including Austria, Italy, Belgium, Spain, and France.
株価
$34.40
最終同期: 2025-08-11
時価総額
$396.01M
変化(1日)
1.83%
変化(1年)
0.00%
DE
取引 PharmaSGP Holding SE (PSG)

カテゴリー

PharmaSGP Holding SE(PSG)の配当利回りの履歴
PharmaSGP Holding SE(銘柄コード: PSG)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
PharmaSGP Holding SE(PSG)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)